Publications

Search and Filter Fields

Type into the field below to perform a live search and/or apply filters via the button provided.

  • Clear

5 Publications found…

  • Academic Paper 5 December 2023

    Regulating Artificial Intelligence and Machine Learning-Enabled Medical Devices in Europe and the United Kingdom

    By Phoebe Li et al.

    View post

    Summary CITP publication

    This paper reviews the key themes, challenges and potential solutions raised at two stakeholder workshops and highlights recent attempts to adapt the laws for AI-enabled medical devices (AIeMD) with a special focus on the regulatory proposals in the UK and internationally. The UK regulatory trajectory shows signs of alignment with the US thinking, and yet the European Union model is still the most closely aligned framework.

    Topics

  • Blog post 22 June 2023

    The Atlantic Declaration Action Plan (ADAPT): Artificial Intelligence and data bridge

    By Phoebe Li and Javier Ruiz.

    View post

    Summary CITP publication

    The UK Government has been striving to navigate a distinct regulatory digital regime away from the EU’s precautionary thinking and the recent Atlantic Declaration strengthens the US-UK partnership in leading critical technology innovation. This blog focuses on two aspects of digital collaboration mentioned in the Atlantic Declaration: Artificial Intelligence and data bridge.

    Topics

  • Academic Paper 26 May 2023

    Learning From Experience and Finding the Right Balance in the Governance of Artificial Intelligence and Digital Health Technologies

    By Stephen Gilbert, Stuart Anderson, Martin Daumer, Phoebe Li, Tom Melvin and Robin Williams et al.

    View post

    Summary CITP publication

    Artificial intelligence (AI) and machine learning medical tools have the potential to be transformative in care delivery; however, this change will only be realized if accompanied by effective governance that ensures patient safety and public trust. Recent digital health initiatives have called for tighter governance of digital health. A correct balance must be found between ensuring product safety and performance while also enabling the innovation needed to deliver better approaches for patients and affordable efficient health care for society. This requires innovative, fit-for-purpose approaches to regulation. Digital health technologies, particularly AI-based tools, pose specific challenges to the development and implementation of functional regulation. The approaches of regulatory science and “better regulation” have a critical role in developing and evaluating solutions to these problems and ensuring effective implementation. We describe the divergent approaches of the European Union and the United States in the implementation of new regulatory approaches in digital health, and we consider the United Kingdom as a third example, which is in a unique position of developing a new post-Brexit regulatory framework.

    Topics

  • Evidence 3 April 2023

    Britain in the World

    By Emily Lydgate, Michael Gasiorek, L. Alan Winters CB, Ingo Borchert, Phoebe Li, Minako Morita Jaeger, Mattia Di Ubaldo and Maria Savona.

    View post

    Summary CITP publication

    Response to the Labour Party National Policy Forum Consultation 2023 providing recommendations on trade policy and growth; digital economy and digital trade policy; international trade, worker and human rights, domestic decarbonization and environmental objectives and trade resilience and economic security.

    Topics

  • Blog post 8 June 2022

    Parallel import and the UK cost-of-living crisis

    By Phoebe Li.

    View post

    Summary CITP publication

    The UK is one of the top IP exporters in the global economy. Changing to an international exhaustion system would lead to domestic revenue losses for many brand manufacturers and bring adverse effects on the creative industries. It is unlikely that the UK will move to this system due to complexities, but that gives IP holders market monopolistic power which inevitably leads to the unilateral power to set market price, leaving consumers to either bear the burden of prices or able to only access unbranded products.

    Topics